Author(s):
Patil Bhagyashri Sandip, Javesh.K. Patil, Chaudhari Hemangi Somnath, Patil Bhagyashri Sunil
Email(s):
bhagyashripatil5853@gmail.com , javesh4u@gmail.com
DOI:
10.52711/2231-5675.2025.00038 
Address:
Patil Bhagyashri Sandip, Javesh.K. Patil, Chaudhari Hemangi Somnath, Patil Bhagyashri Sunil
P.S.G.V.P. Mandal’s College of Pharmacy, Shahada.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2024
ABSTRACT:
Strong antibiotics like clindamycin, which belong to the lincosamide class, are frequently used to treat bacterial infections, especially those that involve anaerobes and Gram-positive bacteria. The necessity for accurate, dependable, and effective analytical techniques for clindamycin measurement and quality control has grown as pharmaceutical companies work to comply with regulatory regulations. An extensive examination of the different analytical techniques created for the determination of clindamycin in pharmaceutical dosage forms, bulk medications, and biological matrices is presented in this article.The majority of the article is devoted to chromatographic techniques, particularly high-performance liquid chromatography (HPLC), which is still the most popular approach because of its exceptional resilience, accuracy, and precision.We evaluated several detection methods used in conjunction with HPLC, including UV, and fluorescence, as well as advancements in reversed-phase HPLC (RP-HPLC) for separation optimization. We examine alternative methods in addition to chromatography, such as spectrophotometric and electrochemical procedures, each of which has advantages specific to the matrix and analytical requirements. The selection of the type of column, the detection wavelength, and the mobile phase composition are only a few of the different factors that are addressed in depth while developing a method. The International Council for Harmonization (ICH) and other regulatory requirements are consulted for examining key validation criteria, such as linearity, accuracy, precision, limit of detection (LOD), and limit of quantification (LOQ).
Cite this article:
Patil Bhagyashri Sandip, Javesh.K. Patil, Chaudhari Hemangi Somnath, Patil Bhagyashri Sunil. Analytical Perspectives on Clindamycin: Review of Methods in Formulations and Biological Samples. Asian Journal of Pharmaceutical Analysis. 2025; 15(3):243-6. doi: 10.52711/2231-5675.2025.00038
Cite(Electronic):
Patil Bhagyashri Sandip, Javesh.K. Patil, Chaudhari Hemangi Somnath, Patil Bhagyashri Sunil. Analytical Perspectives on Clindamycin: Review of Methods in Formulations and Biological Samples. Asian Journal of Pharmaceutical Analysis. 2025; 15(3):243-6. doi: 10.52711/2231-5675.2025.00038 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-15-3-14
5. REFERENCES:
1. Smieja, M. Current indications for the use of clindamycin: A critical review. Canadian Journal of Infectious Diseases. 1998; 9(1): 22-28. https://doi.org/10.1155/1998/538090
2. Siddiqui, M. R., AlOthman, Z. A., and Rahman, N. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry. 2017; 10(S1): S1409-S1421. https://doi.org/10.1016/j.arabjc.2013.04.016
3. La Follette, G., Gambertoglio, J., White, J. A., Knuth, D. W., and Lin, E. T. Determination of clindamycin in plasma or serum by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography. 1988; 431: 379-388.
4. Fieger-Buschges, H., Schußler, G., Larsimont, V., and Blume, H. Determination of clindamycin in human plasma by high-performance liquid chromatography using coupled columns. Journal of Chromatography B. 1999; 724: 281-286.
5. Orwa, J. A., Vandenbempt, K., Depuydt, S., and Roets, E. Determination of clindamycin from related substances. Journal of Pharmaceutical and Biomedical Analysis. 1999; 20(5): 745-752. https://doi.org/10.1016/S0731-7085(99)00044-3
6. Batzias, G. C., Delis, G. A., and Koutsoviti-Papadopoulou, M. A new HPLC/UV method for the determination of clindamycin in dog blood serum. Journal of Pharmaceutical and Biomedical Analysis. 2004; 35(3): 545-554.
7. Cho, S. H., Im, H. T., Park, W. S., Ha, Y. H., Choi, Y. W., and Lee, K. T. Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector. Biomedical Chromatography. 2005; 19(9): 783-787.
8. Wu, G. K., Gupta, A., Khan, M. A., and Faustino, P. J. Development and application of a validated HPLC method for the determination of clindamycin palmitate hydrochloride in marketed drug products: An optimization of the current USP methodology for assay. Journal of Analytical Sciences, Methods and Instrumentation. 2013; 3(4): 202-211.
9. Mifsud, M., Vella, J., Ferrito, V., Serracino-Inglott, A., Azzopardi, L. M., Sammut Bartolo, N., LaFerla, G., and Sammut, C. A simple HPLC-UV method for the determination of clindamycin in human plasma. Journal of Chemical and Pharmaceutical Research. 2014; 6(1): 696-704.